CAS ID: | 361442-04-8 |
Molecular Formula: | C18H25N3O2 |
Molecular Weight: | 315.4 g/mol |
Monoisotopic Mass: | 315.1947 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | BMS-477118-11 | SAXAGLIPTIN HYDROCHLORIDE | SAXAGLIPTIN | ONGLYZA | BMS-477118 |
Analysis: | Drug repositioning mechanism analysis |
InChI: | InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1 | See All |
InChI Key: | QGJUIPDUBHWZPV-SGTAVMJGSA-N | |
Smiles: | N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4 | See All |
Molfile: | Download |
Trial Record 1
ClinicalTrial ID | NCT02148978 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Unknown |
First Received | May 29, 2014 | Last Verified | May 29, 2014 |
Sponsor | Ram Weiss |
Trial Record 2
ClinicalTrial ID | NCT02239458 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Unknown |
First Received | September 12, 2014 | Last Verified | April 16, 2015 |
Sponsor | Ram Weiss |
PubChem: | 11243969 |
ChEMBL: | CHEMBL385517 |